Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04ZXP
|
||||
| Former ID |
DIB003698
|
||||
| Drug Name |
Dicycloplatin
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Registered | [1] | ||
| Company |
Peking University
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
C1(C(=O)O)(C(=O)O)CCC1.C1(C(=O)[O-])(C(=O)[O-])CCC1.[Pt<br />+2].N.N
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031375) | ||||
| REF 2 | Dicycloplatin, a novel platinum analog in chemotherapy: synthesis of chinese pre-clinical and clinical profile and emerging mechanistic studies. Anticancer Res. 2014 Jan;34(1):455-63. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.